HeliTrax is also equipped with a camera to document bleeding events. Patients can quickly capture a high-quality picture of the bleed, which can then be seamlessly transmitted electronically to their treatment team, who can assess the seriousness of the event and often save the patient from making unnecessary trips to the emergency room.
"This innovative device uses cutting-edge technology to help those living with a bleeding disorder to manage their condition," said Garrett E. Bergman M.D., Senior Director of U.S. Medical Affairs at CSL Behring. "CSL Behring is committed to the bleeding disorder community and continues to develop creative management tools with the patient in mind."
Hemophilia primarily affects young males and managing their disease can be challenging for them and their parents. Shirley Smith of Hariman, Tennessee, has been using the HeliTrax System to manage her 10-year-old son Tyler's severe hemophilia and Factor VIII deficiency since October 2007.
"I love it," says Smith. "As complicated as things are when you have a child with hemophilia, the HeliTrax System just makes life 150 percent easier."
For more information about Helixate FS and HeliTrax please go to http://www.cslbehring.com or call CSL Behring Consumer Affairs at 1-888-508-6978.
About Helixate(R) FS
Helixate(R) FS is a recombinant factor VIII treatment for hemophilia A that offers convenient administration with a 2.5 mL volume diluent; no available factor VIII product has a smaller diluent size. The 2000 IU vial size requires a 5.0 mL volume diluent.
No albumin is used in the formulation or purification of Helixate FS,
and its manufacture includes a solvent/detergent viral inactivation step.
The most frequently re
|SOURCE CSL Behring|
Copyright©2008 PR Newswire.
All rights reserved